The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Revised Response Criteria for Malignant Lymphoma
Open accessAbstract
Purpose: Standardized response criteria are needed to interpret and compare clinical trials and for approval of new therapeutic agents by regulatory agencies. Methods: The International Working Group response criteria (Cheson et al, J Clin Oncol 17:1244, 1999) were widely adopted, but required reassessment because of identified limitations and the increased use of [18 F]fluorodeoxyglucose-positron emission tomography (PET), immunohistochemistry (IHC), and flow cytometry. The International Harmonization Project was convened to provide updated recommendations. Results: New guidelines are presented incorporating PET, IHC, and flow cytometry for definitions of response in non-Hodgkin's and Hodgkin's lymphoma. Standardized definitions of end points are provided. Conclusion: We hope that these guidelines will be adopted widely by study groups, pharmaceutical and biotechnology companies, and regulatory agencies to facilitate the development of new and more effective therapies to improve the outcome of patients with lymphoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1244 · Cited by 3,486
Self-citationWotherspoon, A. C., Diss, T. C., Pan, L., Isaacson, P. G., Doglioni, C., Moschini, A., & de Boni, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91409-f · Cited by 2,118
Juweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., Wiseman, G. A., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,335
Self-citationAbrey, L. E., Batchelor, T. T., Ferreri, A. J. M., Gospodarowicz, M., Pulczynski, E. J., Zucca, E., Smith, J. R., Korfel, A., Soussain, C., DeAngelis, L. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.524 · Cited by 914
Self-citationPositron-Emission Tomography and Assessment of Cancer Therapy
Juweid, M. E., & Cheson, B. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050276 · Cited by 750
Self-citationHutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Buhl, T., Jurlander, J., Buus, S., Keiding, S., D'Amore, F., Boesen, A.-M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2252 · Cited by 726
Self-citationJerusalem, G., Beguin, Y., Fassotte, M. F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999) · Blood · doi:10.1182/blood.v94.2.429 · Cited by 565
Haioun, C., Itti, E., Rahmouni, A., Brice, P., Rain, J.-D., Belhadj, K., Gaulard, P., Garderet, L., Lepage, E., Reyes, F., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0272 · Cited by 494
Spaepen, K., Stroobants, S., Dupont, P., Van Steenweghen, S., Thomas, J., Vandenberghe, P., Vanuytsel, L., Bormans, G., Balzarini, J., De Wolf-Peeters, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.414 · Cited by 465
Self-citationUtility of FDG-PET scanning in lymphoma by WHO classification
Elstrom, R., Guan, L., Baker, G., Nakhoda, K., Vergilio, J.-A., Zhuang, H., Pitsilos, S., Bagg, A., Downs, L., Mehrotra, A., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2778 · Cited by 437
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Thomas, J., de Groot, T., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L., & Verhoef, G. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf256 · Cited by 410
Self-citationMikhaeel, N. G., Hutchings, M., Fields, P. A., O'Doherty, M. J., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi272 · Cited by 401
Juweid, M. E., Wiseman, G. A., Vose, J. M., Ritchie, J. M., Menda, Y., Wooldridge, J. E., Mottaghy, F. M., Rohren, E. M., Blumstein, N. M., Stolpen, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.891 · Cited by 387
Self-citationNeubauer, A., Thiede, C., Alpen, B., Ritter, M., Neubauer, B., Ehninger, G., Morgner, A., Bayerdorffer, E., Wundisch, T., & Stolte, M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.18.1350 · Cited by 293
Gallamini, A., Rigacci, L., Merli, F., Nassi, L., Bosi, A., Capodanno, I., Luminari, S., Vitolo, U., Sancetta, R., D, E. I. M., et al. (2006) · PubMed · Cited by 293
Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M. F., Rigo, P., & Fillet, G. (2001) · Annals of Oncology · doi:10.1023/a:1011169332265 · Cited by 268
Stumpe, K. D. M., Urbinelli, M., Steinert, H. C., Glanzmann, C., Buck, A., & von Schulthess, G. K. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050275 · Cited by 261
Bangerter, M., Moog, F., Buchmann, I., Kotzerke, J., Griesshammer, M., Hafner, M., Elsner, K., Frickhofen, N., Reske, S. N., & Bergmann, L. (1998) · Annals of Oncology · doi:10.1023/a:1008486928190 · Cited by 244
Buchmann, I., Reinhardt, M., Elsner, K., Bunjes, D., Altehoefer, C., Finke, J., Moser, E., Glatting, G., Kotzerke, J., Guhlmann, C. A., et al. (2001) · Cancer · doi:10.1002/1097-0142(20010301)91:5<889::aid-cncr1078>3.0.co;2-5 · Cited by 239
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Maertens, J., Bormans, G., Thomas, J., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3842 · Cited by 226
Self-citationJerusalem, G., Beguin, Y., Fassotte, M. F., Belhocine, T., Hustinx, R., Rigo, P., & Fillet, G. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg011 · Cited by 215
Kostakoglu, L., Leonard, J. P., Kuji, I., Coleman, M., Vallabhajosula, S., & Goldsmith, S. J. (2002) · Cancer · doi:10.1002/cncr.10336 · Cited by 212
Naumann, R., Vaic, A., Beuthien‐Baumann, B., Bredow, J., Kropp, J., Kittner, T., Franke, W., & Ehninger, G. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03147.x · Cited by 212
Jérusalem, G., Beguin, Y. P., Fassotte, M., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2001) · PubMed · Cited by 204
Karam, M., Novak, L., Cyriac, J., Ali, A., Nazeer, T., & Nugent, F. (2006) · Cancer · doi:10.1002/cncr.21967 · Cited by 200
The role of positron emission tomography (PET) in the management of lymphoma patients
Zinzani, P. L., Magagnoli, M., Chierichetti, F., Zompatori, M., Garraffa, G., Bendandi, M., Gherlinzoni, F., Cellini, C., Stefoni, V., Ferlin, G., et al. (1999) · Annals of Oncology · doi:10.1023/a:1008327127033 · Cited by 180
Naumann, R., Beuthien-Baumann, B., Reiß, A., Schulze, J., Hänel, A., Bredow, J., Kühnel, G., Kropp, J., Hänel, M., Laniado, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601561 · Cited by 171
Hoffmann, M., Kletter, K., Diemling, M., Becherer, A., Pfeffel, F., Petkov, V., Chott, A., & Raderer, M. (1999) · Annals of Oncology · doi:10.1023/a:1008312726163 · Cited by 165
Jérusalem, G., Warland, V., Najjar, F., PAULUS, P., Fassotte, M., Fillet, G., & Rigo, P. (1999) · Nuclear Medicine Communications · doi:10.1097/00006231-199901000-00004 · Cited by 157
Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission.
Weeks, J. C., Yeap, B. Y., Canellos, G. P., & Shipp, M. A. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1196 · Cited by 149
Zinzani, P. L., Tani, M., Fanti, S., Alinari, L., Musuraca, G., Marchi, E., Stefoni, V., Castellucci, P., Fina, M., Farshad, M., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl122 · Cited by 149
Thiede, C., Wündisch, T., Alpen, B., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1600 · Cited by 120
Liedtke, M., Hamlin, P. A., Moskowitz, C. H., & Zelenetz, A. D. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl049 · Cited by 103
Castellucci, P., Nanni, C., Farsad, M., Alinari, L., Zinzani, P. L., Stefoni, V., Battista, G., Valentini, D., Pettinato, C., Marengo, M., et al. (2005) · Nuclear Medicine Communications · doi:10.1097/01.mnm.0000171781.11027.bb · Cited by 96
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease
Querellou, S., Valette, F., Bodet‐Milin, C., Oudoux, A., Carlier, T., Harousseau, J., Chatal, J., & Couturier, O. (2006) · Annals of Hematology · doi:10.1007/s00277-006-0151-z · Cited by 61
International harmonization of trial parameters in malignant lymphoma
Pfistner, B., Diehl, V., Greb, A., & Cheson, B. D. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00455.x · Cited by 14
Self-citation
Cited by
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030
Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8800 · Cited by 5,715
Self-citationFrom RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
“Progression in the lungs, particularly in the presence of potential inflammation or infection while a patient is on treatment, should be viewed with great caution, as discussed in the revised response criteria in lymphoma (32,33).”
BackgroundMethodInfluentialLee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898
Metadata
- Authors
- Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., Rosen, S. T., Stroobants, S., Lister, T. A., Hoppe, R. T., Dreyling, M., Tobinai, K., Vose, J. M., Connors, J. M., Federico, M., & Diehl, V.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-02-10
- Volume
- 25
- Issue
- 5
- Pages
- 579-586
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2133201432
- Cited by
- 4,426
- References
- 36
- FWCI
- 108.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.